# Lenalidomide

NDC: 59651-345
Generic name: Lenalidomide
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230306

FDA application: ANDA213885

## Active ingredients

- LENALIDOMIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-345"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-345
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51bfdd53-8fd9-4f86-bebe-75de29e6379d